In his role as President and Chief Operating Officer (COO), Dr. Goldberg leads PAREXEL’s global management team to capitalize on the strong market opportunity for global biopharmaceutical services. His remit includes P&L responsibility for all of the Company’s business units, which total approximately $2 billion in revenue per annum.  In addition, Dr. Goldberg focuses on further strengthening client relationships, as well as leveraging PAREXEL’s leadership role in the convergence of services and technology in support of clinical research.Dr. Goldberg has been an asset to PAREXEL’s executive management team for more than 19 years, applying his combined business, medical, technical, and clinical research expertise. During this time, Dr. Goldberg has held roles of increasing responsibility. He previously served as President of Clinical Research Services and Perceptive Informatics (now PAREXEL Informatics), and continues to oversee these areas of the Company. In his role as President and Chief Operating Officer (COO), Dr. Goldberg leads PAREXEL’s global management team to capitalize on the strong market opportunity for global biopharmaceutical services. His remit includes P&L responsibility for all of the Company’s business units, which total approximately $2 billion in revenue per annum.  In addition, Dr. Goldberg focuses on further strengthening client relationships, as well as leveraging PAREXEL’s leadership role in the convergence of services and technology in support of clinical research.Dr. Goldberg has been an asset to PAREXEL’s executive management team for more than 19 years, applying his combined business, medical, technical, and clinical research expertise. During this time, Dr. Goldberg has held roles of increasing responsibility. He previously served as President of Clinical Research Services and Perceptive Informatics (now PAREXEL Informatics), and continues to oversee these areas of the Company.

Dr. Goldberg is expertise in buisiness, medical, technical, clinical research.